Literature DB >> 3101814

Prognosis of children who are carriers of hepatitis B.

S M Wheeley, E H Boxall, M J Tarlow.   

Abstract

Fifteen children who had become positive for hepatitis B surface antigen (HBsAg) by perinatal transmission were traced and re-examined after a mean of 8.1 years; all had been born in England to mothers from ethnic minorities who were carriers of HBsAg. Fourteen of the children remained carriers of HBsAg; of these, more girls than boys developed antibody to hepatitis B e antigen (anti-HBe). Those children whose transaminase activities had been above normal within the first three years of life were more likely to have developed anti-HBe. The earlier production of anti-HBe suggests that girls have a more effective immune response. Increased transaminase activity early in the course of asymptomatic carriage of HBsAg may be a favourable prognostic sign.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3101814      PMCID: PMC1245227          DOI: 10.1136/bmj.294.6566.211

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Sex distribution of Australia antigen.

Authors:  B S Blumberg; A I Sutnick; W T London; L Melartin
Journal:  Arch Intern Med       Date:  1972-08

3.  Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma.

Authors:  L I Lutwick
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

4.  Hepatoma in an HBsAg carrier--seven years after perinatal infection.

Authors:  R P Beasley; I S Shiao; T C Wu; L Y Hwang
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

5.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  G Realdi; A Alberti; M Rugge; F Bortolotti; A M Rigoli; F Tremolada; A Ruol
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

6.  The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in Great Britain.

Authors:  L A Viola; I G Barrison; J C Coleman; F J Paradinas; I M Murray-Lyon
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

7.  Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

Authors:  P Karayiannis; M J Fowler; A S Lok; C Greenfield; J Monjardino; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

8.  Infection with hepatitis B virus in infancy. A longitudinal study of 8 cases.

Authors:  P Skinhøj
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

9.  Sex differences in response to hepatitis B virus. I. History.

Authors:  B S Blumberg
Journal:  Arthritis Rheum       Date:  1979-11

10.  Transmission of HBsAg from mother to infant in four ethnic groups.

Authors:  A Derso; E H Boxall; M J Tarlow; T H Flewett
Journal:  Br Med J       Date:  1978-04-15
View more
  4 in total

1.  Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B.

Authors:  D Westmoreland; V Player; D C Heap; A Hammond
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

2.  Natural history of hepatitis B in perinatally infected carriers.

Authors:  E H Boxall; J Sira; R A Standish; P Davies; E Sleight; A P Dhillon; P J Scheuer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

Review 3.  Molecular hybridization techniques in current diagnosis of chronic hepatitis B in childhood.

Authors:  S Wirth; B Zabel
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

4.  Hepatitis B virus infection in Northern Ireland 1970-1987.

Authors:  J H Connolly; W M McClelland; H J O'Neill; D Crowley
Journal:  Ulster Med J       Date:  1989-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.